600196 Shanghai Fosun Pharmaceutical
- 23.20
- -0.43-1.82%
Shanghai Fosun Pharmaceutical News
Fosun Pharmaceutical H Share Announcement
Fosun Pharmaceutical H Share Announcement
Fosun Pharmaceutical's announcement that its holding subsidiary has been approved for a supplementary drug application
Announcement of Fosun Pharmaceutical on providing guarantees for holding subsidiaries
Fosun Pharmaceutical's announcement on the progress of the licensing agreement for its holding subsidiary
Announcement of Resolutions of the 50th Meeting (Interim Meeting) of the 9th Board of Directors of Fosun Pharmaceutical
Announcement of Resolutions of the 4th Meeting (Interim Meeting) of the 9th Board of Supervisors of Fosun Pharmaceutical in 2024
Fosun Pharmaceutical's announcement on the signing of a capital increase and stock expansion agreement by its holding subsidiary
Fosun Pharmaceutical's announcement on amending the “Articles of Association” and its annexes
Announcement of Fosun Pharmaceutical on the approval of its holding subsidiary for drug clinical trials
Fosun Pharmaceutical's announcement on the approval of its holding subsidiary for drug registration
Fosun Pharmaceutical's Announcement on Holding Results Briefings for the First Quarter of 2023 and 2024
Announcement of Fosun Pharmaceutical on providing guarantees for holding subsidiaries
Fosun Pharmaceutical H Share Announcement-Monthly Statement of Securities Changes
Fosun Pharmaceutical's announcement that its holding subsidiary has been approved for clinical trials of drugs by the US FDA
Fosun Pharmaceutical's progress announcement on the repurchase of shares through centralized bidding
Announcement of Resolutions of the 49th Meeting (Regular Meeting) of the 9th Board of Directors of Fosun Pharmaceutical
Fosun Pharmaceuticals 2024 First Quarter Report
Fosun Pharmaceutical's announcement on providing loans and related transactions to joint ventures according to shareholding ratio
Fosun Pharmaceutical's announcement on the approval of its holding subsidiary for drug registration
Analysis
Price Target
No Data
